Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Prostatic Neoplasms 52 Brain Neoplasms 50 Carcinoma, Non-Small-Cell Lung 48 Neoplasm Metastasis 29 Lung Neoplasms 29 Breast Neoplasms 23 Pancreatic Neoplasms 16 Melanoma 15 Carcinoma, Renal Cell 14 Carcinoma, Hepatocellular 13 Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Urinary Bladder Neoplasms 7 Small Cell Lung Carcinoma 7 Colorectal Neoplasms 7 Kidney Neoplasms 5 Liver Neoplasms 4 Glioblastoma 4 Uveal Melanoma 3 Triple Negative Breast Neoplasms 3 Spinal Cord Neoplasms 3 Sarcoma 3 Prostate Cancer Metastatic 3 NSCLC 3 Meningioma 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 Gastrointestinal Neoplasms 3 Carcinoma, Transitional Cell 3 Adenocarcinoma 3

Interventions

pembrolizumab 12 Pemetrexed 9 Cisplatin 9 Nivolumab 8 Carboplatin 8 Ipilimumab 7 Cyclophosphamide 6 fludarabine 5 durvalumab 4 tremelimumab 2 Radiotherapy, Intensity-Modulated 2 Gemcitabine 2 Cerebral Decortication 2 tocilizumab 1 tislelizumab 1 tazemetostat 1 sotorasib 1 ruxolitinib 1 osimertinib 1 olaparib 1 obinutuzumab 1 naptumomab estafenatox 1 fludarabine phosphate 1 decitabine and cedazuridine drug combination 1 bintrafusp alfa protein, human 1 avelumab 1 atezolizumab 1 Tumor Burden 1 Tablets 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma × Radiosurgery × 1 year × Clear all

NCT04166734 2026-02-04

MESO-PRIME

Royal Marsden NHS Foundation Trust

Phase 1 Terminated

5 enrolled 13 charts

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡